Health and Fitness Health and Fitness

Fri, June 8, 2012

[ Fri, Jun 08th 2012 ] - Market Wire

Amgen Announces Top-Line Results Of Phase 3 Sensipar/Mimpara EVOLVEa" Trial

[ Fri, Jun 08th 2012 ] - Market Wire

Today's Market Driven by Key Factors - Featured R .. arch on Endo Health Solutions Inc and Intuit Inc.

[ Fri, Jun 08th 2012 ] - Market Wire

Calendar of Events - Report Highlights Valeant Pharmaceuticals Int (USA) and Zimmer Holdings, Inc.

[ Fri, Jun 08th 2012 ] - Market Wire

Calendar of Events - Report Highlights Stryker Corporation and Huntsman Corporation

[ Fri, Jun 08th 2012 ] - Market Wire

Equities Lead Investor Sentiment - Research Repor .. armaceuticals Inc and Elan Corporation, plc (ADR)

[ Fri, Jun 08th 2012 ] - Market Wire

Calendar of Events - Report Highlights Amarin Corporation plc (ADR) and Warner Chilcott Plc

[ Fri, Jun 08th 2012 ] - Market Wire

Equities Lead Investor Sentiment - Research Repor .. on Allergan, Inc. and Qihoo 360 Technology Co Ltd

[ Fri, Jun 08th 2012 ] - Market Wire

Edwards Receives IDE for U.S. Clinical Trial of New Heart Valve Tissue Treatment Platform

[ Fri, Jun 08th 2012 ] - Market Wire

Mylan Settles Provigil Litigation With Teva

[ Fri, Jun 08th 2012 ] - Market Wire

China Biologic to Postpone Annual General Meeting of Shareholders

[ Fri, Jun 08th 2012 ] - Market Wire

Karen S. Rohan to Head Aetnaas Specialty Products Organization

[ Fri, Jun 08th 2012 ] - Market Wire

Magellan Health Services Announces Departure of Karen S. Rohan

[ Fri, Jun 08th 2012 ] - Market Wire

Alnylam Completes Enrollment in Phase I Clinical .. Clinical Trial of ALN-TTR02, an RNAi Therapeutic

[ Fri, Jun 08th 2012 ] - Market Wire

Celgene progresa en el desarrollo de ABRAXANE (nab-paclitaxel) en cnceres con difcil tratamiento

[ Fri, Jun 08th 2012 ] - Market Wire

POZEN to Present at the 2012 Wells Fargo Securities Healthcare Conference

[ Fri, Jun 08th 2012 ] - Market Wire

Mallinckrodt and Zogenix Announce Exclusive Co-Promotion Arrangement on SUMAVEL DosePro

[ Fri, Jun 08th 2012 ] - Market Wire

Daten aus der Nachfolgestudie zu KALYDECOa" (Ivac .. esserungen der Lungenfunktion und anderer Krankhe

[ Fri, Jun 08th 2012 ] - Market Wire

Les donnes issues de l'tude de suivi de KALYDECOa .. amliorations de la fonction pulmonaire et d'autre

[ Fri, Jun 08th 2012 ] - Market Wire

Centene Corporation Selected for Ohio Medicaid Contract

Thu, June 7, 2012

[ Thu, Jun 07th 2012 ] - Market Wire

Dr. Reddyas Announces the Launch of Ropinirole Hydrochloride XR (Extended-Release) Tablets

[ Thu, Jun 07th 2012 ] - Market Wire

ICU Medical's ChemoClavea" System Included in Mob .. apeutics' Mitosol Kit for Use in Glaucoma Surgery

[ Thu, Jun 07th 2012 ] - Market Wire

Sunshine Heart Receives Health Canada Approval to .. tional Study to Use the Next Generation C-Pulse(R

[ Thu, Jun 07th 2012 ] - Market Wire

JDRF and BD Collaborate to Develop More Accurate .. onitoring Devices for People with Type 1 Diabetes

[ Thu, Jun 07th 2012 ] - Market Wire

Calender of Events - Report Highlights Sanofi SA .. ADR) and Teva Pharmaceutical Industries Ltd (ADR)

[ Thu, Jun 07th 2012 ] - Market Wire

Calender of Events - Report Highlights Questcor Pharmaceuticals, Inc. and Eastman Chemical Company

[ Thu, Jun 07th 2012 ] - Market Wire

CyberKnife Prostate SBRT Outcomes and Quality of .. sented at American Urological Association Meeting

[ Thu, Jun 07th 2012 ] - Market Wire

QuantRx Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments

[ Thu, Jun 07th 2012 ] - Market Wire

American Medical Systems and Allergan Sign Agreement for JetToucha"/BOTOX Co-Development Program

[ Thu, Jun 07th 2012 ] - Market Wire

Pfizer and Staples Shares Dip as U.S. Job Growth .. -- S&;;P 500 Falls 10% From 4-Year High

[ Thu, Jun 07th 2012 ] - Market Wire

Research on Brookdale Senior Living Inc. and Sunr .. -Term Care Facilities Up and Demand Down on Reimb

[ Thu, Jun 07th 2012 ] - Market Wire

USANA Health Sciences Expands Team of Advising Scientific Experts

[ Thu, Jun 07th 2012 ] - Market Wire

First sales of DIFICLIRa" by Astellas Pharma Euro .. Euro Milestone Payment to Optimer Pharmaceuticals

[ Thu, Jun 07th 2012 ] - Market Wire

GenVec Announces Conditional Approval of FMD Vaccine for Cattle

[ Thu, Jun 07th 2012 ] - Market Wire

Discovery Labs to Present AFECTAIR Data at European Congress on Pediatric and Neonatal Ventilation

[ Thu, Jun 07th 2012 ] - Market Wire

Boston Therapeutics Secures DTC Eligibility

[ Thu, Jun 07th 2012 ] - Market Wire

Sunrise Senior Living Enters Agreement to Transfe .. Seven Sunrise Communities to a New Joint Venture

[ Thu, Jun 07th 2012 ] - Market Wire

Titan Medical Inc. Announces Addition of Dr. Dennis L. Fowler, MD, MPH as Development Consultant

[ Thu, Jun 07th 2012 ] - Market Wire

Syneron annuncia il lancio internazionale della p .. voro per trattamenti estetici con sistema ePlusa"

Wed, June 6, 2012

[ Wed, Jun 06th 2012 ] - Market Wire

Amarantus BioSciences and Banyan Biomarkers Annou .. ve Data from Traumatic Brain Injury Collaboration

[ Wed, Jun 06th 2012 ] - Market Wire

Boston Scientific to Present an Overview of its Endoscopy Business

[ Wed, Jun 06th 2012 ] - Market Wire

ERT Announces Clearance from German Federal Cartel Office

[ Wed, Jun 06th 2012 ] - Market Wire

Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7th

[ Wed, Jun 06th 2012 ] - Market Wire

Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board

[ Wed, Jun 06th 2012 ] - Market Wire

West Announces Expiration and Final Results of Ca .. ll of Its 4.00% Convertible Junior Subordinated D

[ Wed, Jun 06th 2012 ] - Market Wire

Research on Celgene Corporation and Gilead Scienc .. s Inc. - Biotech Firms Focusing on Cancer and HIV

[ Wed, Jun 06th 2012 ] - Market Wire

The Medicines Company Prices $225 Million of Convertible Notes

[ Wed, Jun 06th 2012 ] - Market Wire

Rosetta Genomics Appoints Roy N. Davis to Board of Directors

[ Wed, Jun 06th 2012 ] - Market Wire

Mylan Canada Receives Health Canada Approval for Generic Version of Tracleer

[ Wed, Jun 06th 2012 ] - Market Wire

Medivation and Astellas Provide Update on PREVAIL Enrollment

[ Wed, Jun 06th 2012 ] - Market Wire

Step Study Results Demonstrate Sustained Therapeu .. ercutaneous Tibial Nerve Stimulation at 24 Months

[ Wed, Jun 06th 2012 ] - Market Wire

IRIDEX Announces First Endo-MicroPulsea" Laser Surgery

[ Wed, Jun 06th 2012 ] - Market Wire

Orexigen Therapeutics and Sharecare Announce Part .. Matea", a Comprehensive Weight Management Program

[ Wed, Jun 06th 2012 ] - Market Wire

China Cord Blood Corporation to Report Fourth Qua .. er and Full Year of Fiscal 2012 Financial Results

[ Wed, Jun 06th 2012 ] - Market Wire

Amarantus BioSciences to Present at the National .. ciation's (NIBA)122nd Conference in New York City

[ Wed, Jun 06th 2012 ] - Market Wire

Syneron anuncia lanamento internacional de plataf .. ma integral de tratamentos mdico-estticos ePlusa"

[ Wed, Jun 06th 2012 ] - Market Wire

Syneron Announces International Launch of the ePlusa" Complete Aesthetic Work Station

Tue, June 5, 2012

[ Tue, Jun 05th 2012 ] - Market Wire

Alexion to Present at William Blair & Company 32nd Annual Growth Stock Conference

[ Tue, Jun 05th 2012 ] - Market Wire

Aetnaas Bismarck Employees Reach $1 Million Miles .. in Volunteer Council Donations to Local Charities

[ Tue, Jun 05th 2012 ] - Market Wire

The Ensign Group Acquires Texas Skilled Nursing Facility

[ Tue, Jun 05th 2012 ] - Market Wire

ISTA Pharmaceuticals Stockholders Vote to Approve Acquisition by Bausch + Lomb

[ Tue, Jun 05th 2012 ] - Market Wire

Investigation of Acorda Therapeutics, Inc. by Sec .. farb LLP Law Firm for Potential Shareholder Claim

[ Tue, Jun 05th 2012 ] - Market Wire

Strontium Validation Completed at Positron's Lubbock, Texas Facility

[ Tue, Jun 05th 2012 ] - Market Wire

Critical Alerts For Amgen, United Continental, D. .. y, and MDC Holdings Released By InvestorsObserver

[ Tue, Jun 05th 2012 ] - Market Wire

Relentless Improvements in Throughput, Read-lengt .. d Market Adoption of Ion PGMa" Benchtop Sequencer

[ Tue, Jun 05th 2012 ] - Market Wire

MIT Announces Funding Commitments

[ Tue, Jun 05th 2012 ] - Market Wire

Sitoa Global Launches International E-Commerce Site ShopShip2PH

[ Tue, Jun 05th 2012 ] - Market Wire

IsoRay Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors

[ Tue, Jun 05th 2012 ] - Market Wire

Phase 1 Data for Perifosine in Multiple Myeloma Published in the British Journal of Haematology

[ Tue, Jun 05th 2012 ] - Market Wire

The Medicines Company Announces Intention to Offer $200 Million of Convertible Notes

[ Tue, Jun 05th 2012 ] - Market Wire

EnteroMedics Announces First Commercial Implants of the Maestro(R) Rechargeable System

[ Tue, Jun 05th 2012 ] - Market Wire

Oncolytics Biotech Inc. Enters into Sponsorship A .. ndomized Phase II Study in Non-Small Cell Lung Ca

[ Tue, Jun 05th 2012 ] - Market Wire

Isis Pharmaceuticals to Present a General Corpora .. 012 Annual Meeting of Stockholders and Open House

[ Tue, Jun 05th 2012 ] - Market Wire

OncoSec Medical Inc. Enters Into Exclusive Manufa .. Inc. for Production of Interleukin-12 Plasmid DNA

[ Tue, Jun 05th 2012 ] - Market Wire

Biodel Announces Data Presentations at American Diabetes Association Annual Meeting

Mon, June 4, 2012

[ Mon, Jun 04th 2012 ] - Market Wire

BioSpecifics Technologies Corp. to Present at Jefferies 2012 Global Healthcare Conference

[ Mon, Jun 04th 2012 ] - Market Wire

XTL Biopharmaceuticals Files Application for Listing on the NASDAQ

[ Mon, Jun 04th 2012 ] - Market Wire

Pharmacyclics Announces Updated Results for BTK I .. ) at American Society of Clinical Oncology (ASCO)

[ Mon, Jun 04th 2012 ] - Market Wire

Immunovaccine's DPX-0907 Demonstrates Ability to .. onses in Multiple Cancers in a Clinical Trial Pre

[ Mon, Jun 04th 2012 ] - Market Wire

Tesamorelin Filed for Marketing Approval in Colombia and Venezuela

[ Mon, Jun 04th 2012 ] - Market Wire

Patients With Most Common Type Of Lung Cancer Liv .. ith ALIMTA-Based Continuation Maintenance Therapy

[ Mon, Jun 04th 2012 ] - Market Wire

Boston Scientific Receives FDA Approval for 32 MM .. MUS Elementa" Plus Platinum Chromium Stent System

[ Mon, Jun 04th 2012 ] - Market Wire

AcelRx Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

[ Mon, Jun 04th 2012 ] - Market Wire

Digirad Announces Deadline for Submission of Stockholder Proposals at 2012 Annual Meeting

[ Mon, Jun 04th 2012 ] - Market Wire

Merus Labs International Inc. Signs Product Acquisition Letter of Intent

[ Mon, Jun 04th 2012 ] - Market Wire

John M. Climaco Appointed to Digirad Board of Directors

[ Mon, Jun 04th 2012 ] - Market Wire

Sequenom Announces Participation At The William Blair amp;; Company Growth Stock Conference

[ Mon, Jun 04th 2012 ] - Market Wire

Phase 3 Data for Perifosine in Colorectal Cancer Presented at ASCO Meeting

[ Mon, Jun 04th 2012 ] - Market Wire

AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million

[ Mon, Jun 04th 2012 ] - Market Wire

USANA Becomes Official Health Supplement Supplier .. Korean Men's And Women's National Handball Teams

[ Mon, Jun 04th 2012 ] - Market Wire

ShangPharma and Lilly Celebrate 10 Years of Partnership

[ Mon, Jun 04th 2012 ] - Market Wire

WuXi PharmaTech Addresses Conviction of Former Employee for Theft of Chemical Compounds

[ Mon, Jun 04th 2012 ] - Market Wire

Cees Heiman Joins The Medicines Company to Lead Europe and Middle East Business

Sat, June 2, 2012

[ Sat, Jun 02nd 2012 ] - Market Wire

Oncothyreon Announces Presentation of PX-866 Clin .. n Association of Clinical Oncology Annual Meeting

[ Sat, Jun 02nd 2012 ] - Market Wire

Health Net Announces Appearance at Goldman Sachs 33rd Annual Global Healthcare Conference

[ Sat, Jun 02nd 2012 ] - Market Wire

HCA to Present at Health Care Conference in June

[ Sat, Jun 02nd 2012 ] - Market Wire

Medivation and Astellas Announce Enzalutamide Dat .. Measures and Extension of Time to First Skeletal

[ Sat, Jun 02nd 2012 ] - Market Wire

Human Genome Sciences Response to GSK Press Release

[ Sat, Jun 02nd 2012 ] - Market Wire

St. Jude Medical anuncia la autorizacin europea y .. enervacin renal EnligHTN para el tratamiento de l

[ Sat, Jun 02nd 2012 ] - Market Wire

Las primeras conclusiones del ensayo FAME II reve .. el PCI basado en RFF supera al tratamiento mdico

[ Sat, Jun 02nd 2012 ] - Market Wire

Sirona Expands its Exclusive Distribution Agreement with Patterson Companies, Inc.

Fri, June 1, 2012

[ Fri, Jun 01st 2012 ] - Market Wire

The Ensign Group to Present at the Jefferies 2012 Global Healthcare Conference on June 6, 2012

[ Fri, Jun 01st 2012 ] - Market Wire

BetterInvesting Magazine Releases August Stock to .. Choices for Investors' Informational and Educatio

[ Fri, Jun 01st 2012 ] - Market Wire

United BioSource Corp Scientists to Present at 17 .. al ISPOR Meeting in Washington, DC June 2-6, 2012

[ Fri, Jun 01st 2012 ] - Market Wire

IDEXX Laboratories to Present at William Blair 32nd Annual Growth Stock Conference

[ Fri, Jun 01st 2012 ] - Market Wire

DiaMedica's DM-204 Program Selected for Late Brea .. he American Diabetes Association's 72nd Scientifi

[ Fri, Jun 01st 2012 ] - Market Wire

Abbott Again Recognized as One of the 'Best Places to Work in Industry' by The Scientist Magazine

[ Fri, Jun 01st 2012 ] - Market Wire

Upcoming Economic Outlook - Report Highlights Novartis AG (ADR) and Abbott Laboratories

[ Fri, Jun 01st 2012 ] - Market Wire

Aeolus Pharmaceuticals Announces AEOL 10150 Reduc .. eupogen(R) Treatment Following Radiation Exposure

[ Fri, Jun 01st 2012 ] - Market Wire

HealthSouth Announces Plans To Build Inpatient Rehabilitation Hospital

[ Fri, Jun 01st 2012 ] - Market Wire

Equity Research on Baxter International Inc. and .. - Medical Instruments &;; Supplies Com

[ Fri, Jun 01st 2012 ] - Market Wire

MIT Terminates Equity Financing Arrangement

[ Fri, Jun 01st 2012 ] - Market Wire

Halozyme Therapeutics to Present New Data on the Company's Ultrafast Insulin Programs at ADA 2012

[ Fri, Jun 01st 2012 ] - Market Wire

Transcept Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

[ Fri, Jun 01st 2012 ] - Market Wire

Delaware Chancery Court Issues Final Order And Judgment Upholding Its Favorable Ruling

[ Fri, Jun 01st 2012 ] - Market Wire

Marina Biotech Ceases Most Day-to-Day Operations

[ Fri, Jun 01st 2012 ] - Market Wire

Voluntary Market Withdrawal of Hip Component

[ Fri, Jun 01st 2012 ] - Market Wire

PAREXEL Experts To Address Solutions And Strategi .. uccess At ISPOR 17th Annual International Meeting

[ Fri, Jun 01st 2012 ] - Market Wire

BioLife Solutions Restructures Term Debt;; Secures 3-Year Extension on Maturity

Thu, May 31, 2012

[ Thu, May 31st 2012 ] - Market Wire

Acadia Healthcare to Present at the 2012 Jefferies Global Healthcare Conference

[ Thu, May 31st 2012 ] - Market Wire

Delcath Announces Exercise of Underwriters' Over- .. of $23 Million Public Offering of Common Stock an

[ Thu, May 31st 2012 ] - Market Wire

OPKO Health Receives Core Technology U.S. Patent Allowance

[ Thu, May 31st 2012 ] - Market Wire

Conditions of Growth, Economic Analysis - Research Report on Mylan Inc. and CA, Inc.

[ Thu, May 31st 2012 ] - Market Wire

Paladin Labs to Present at the Jefferies Global Healthcare Conference in New York

[ Thu, May 31st 2012 ] - Market Wire

La Jolla Pharmaceutical Announces Issuance of U.S. Patent Covering Modified Pectin Compositions

[ Thu, May 31st 2012 ] - Market Wire

Data on Two of Rosetta Genomics' Launched Diagnostic Assays to Be Presented at ASCO 2012

[ Thu, May 31st 2012 ] - Market Wire

Shareholder Rights Law Firm Johnson & Weaver, LLP .. nvestigates ViroPharma, Inc. For Securities Fraud

[ Thu, May 31st 2012 ] - Market Wire

Rockwell Medical Completes Patient Enrollment in CRUISE-1 Phase III Clinical Study

[ Thu, May 31st 2012 ] - Market Wire

Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference

[ Thu, May 31st 2012 ] - Market Wire

VentriPoint Announces Appointment of New Chief Financial Officer

[ Thu, May 31st 2012 ] - Market Wire

Omeros Announces Initiation of Planned Pharmacokinetic Substudy in OMS302 Phase 3 Clinical Program

[ Thu, May 31st 2012 ] - Market Wire

Ampio Patent Protection for Optinaa" Expands to Include Europe

[ Thu, May 31st 2012 ] - Market Wire

Alkermesa Corporate Presentation to be Webcast at Two Upcoming Conferences

[ Thu, May 31st 2012 ] - Market Wire

Illumina Introduces Nextera XT DNA Sample Preparation Kits

[ Thu, May 31st 2012 ] - Market Wire

DaVita Schedules Capital Markets Day for June 7, 2012

[ Thu, May 31st 2012 ] - Market Wire

Single Center Data From C-Pulse(R) Feasibility Tr .. to Severe Heart Failure to Be Presented at the 2

[ Thu, May 31st 2012 ] - Market Wire

New Data Showed LIVALO (pitavastatin) Met Primary .. of LDL-C Reduction When Compared with Pravastatin

Wed, May 30, 2012

[ Wed, May 30th 2012 ] - Market Wire

Cannabis Science Creates aCannabis Science Resear .. oks Forward to Inaugural Event in the Near Future

[ Wed, May 30th 2012 ] - Market Wire

Highmark Extends Relationship With Healthways to .. Offer SilverSneakers Fitness Program Through 2013

[ Wed, May 30th 2012 ] - Market Wire

Orthofix International Announces Integration with Brainlab Spinal Image Guided Surgery System

[ Wed, May 30th 2012 ] - Market Wire

Gatorz Inc. Reports Financial Results For the First Quarter Ended March 31, 2012

[ Wed, May 30th 2012 ] - Market Wire

Life Technologies and OpGen Sign Collaborative Ag .. Ion Torrent and Whole Genome Mapping Technologies

[ Wed, May 30th 2012 ] - Market Wire

Sunrise Senior Living Settles Litigation with Five Star Quality Care, Inc.

[ Wed, May 30th 2012 ] - Market Wire

Medivation and Astellas Announce Initiation of Ex .. alutamide (formerly MDV3100) in the United States

[ Wed, May 30th 2012 ] - Market Wire

AVEO Oncology to Host Conference Call and Webcast to Review Phase 3 TIVO-1 Data Presented at ASCO

[ Wed, May 30th 2012 ] - Market Wire

Exelixis Initiates COMET-1 Pivotal Trial Focused .. all Survival in Men With Advanced Prostate Cancer

[ Wed, May 30th 2012 ] - Market Wire

Alnylam Announces Top-Line Results of Phase IIb C .. n Inhaled RNAi Therapeutic for the Treatment of R

[ Wed, May 30th 2012 ] - Market Wire

Former Stryker Executive Robert Housler Jr. Joins .. peutics as Vice President of Business Development

[ Wed, May 30th 2012 ] - Market Wire

Exelixis Completes Submission of New Drug Applica .. nib for the Treatment of Medullary Thyroid Cancer

[ Wed, May 30th 2012 ] - Market Wire

Biogen Idec continua nel suo sostegno alla comuni .. celebrazioni a livello internazionale in occasio

[ Wed, May 30th 2012 ] - Market Wire

Biogen Idec untersttzt MS-Gemeinde mit weltweiten Veranstaltungen zum 4. jhrlichen Welt-MS-Tag

[ Wed, May 30th 2012 ] - Market Wire

Biogen Idec continue de soutenir la communaut de .. avec des clbrations internationales l'occasion de

[ Wed, May 30th 2012 ] - Market Wire

Comprehensive Care Corporation Implements Steps to Increase Margins and Sustain Profitability

[ Wed, May 30th 2012 ] - Market Wire

Ono and Galapagos subsidiary BioFocus sign an add .. covery agreement in the field of allergic disease

[ Wed, May 30th 2012 ] - Market Wire

Biogen Idec Continues Support for MS Community wi .. ldwide Celebrations on Fourth Annual World MS Day

Tue, May 29, 2012

[ Tue, May 29th 2012 ] - Market Wire

Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference

[ Tue, May 29th 2012 ] - Market Wire

Bond Laboratories Reports 1st Quarter Results

[ Tue, May 29th 2012 ] - Market Wire

Immunovaccine to Present Clinical Data on its DPX .. 07 Cancer Vaccine at the 2012 ASCO Annual Meeting

[ Tue, May 29th 2012 ] - Market Wire

LISTA DE VERIFICACI"N PARA UN VIAJE SALUDABLE EN LAS VACACIONES DE VERANO

[ Tue, May 29th 2012 ] - Market Wire

Equity Research on Medtronic Inc. and Hologic Inc .. s Focus on International Markets and Acquisitions

[ Tue, May 29th 2012 ] - Market Wire

Research on Pfizer Inc. and Bristol-Myers Squibb .. s Look to Grow Revenues in Wake of Patent Expirie

[ Tue, May 29th 2012 ] - Market Wire

IsoRay's Cesium-131 Prostate Cancer Treatment Featured on Discovery Channel

[ Tue, May 29th 2012 ] - Market Wire

Dyax Corp. to Participate in the Jefferies 2012 Global Healthcare Conference

[ Tue, May 29th 2012 ] - Market Wire

Omeros to Present at Jefferies 2012 Global Healthcare Conference

[ Tue, May 29th 2012 ] - Market Wire

Isis Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

[ Tue, May 29th 2012 ] - Market Wire

Vertex corregge e fornisce ulteriori dati basati .. nea dello studio di combinazione di fase 2 del VX

[ Tue, May 29th 2012 ] - Market Wire

AVEO Oncology to Present at the Jefferies 2012 Global Healthcare Conference

[ Tue, May 29th 2012 ] - Market Wire

OncoSec to Present at BioFinance 2012

[ Tue, May 29th 2012 ] - Market Wire

OncoSec Medical Issues Letter to Shareholders

[ Tue, May 29th 2012 ] - Market Wire

SciClone Increases Stock Repurchase Program

[ Tue, May 29th 2012 ] - Market Wire

PAREXEL Chairman And CEO To Ring The Bell At The NASDAQ Stock Market Opening

[ Tue, May 29th 2012 ] - Market Wire

ShangPharma Corporation Issues Statement in Response to Name Confusion

[ Tue, May 29th 2012 ] - Market Wire

Santarus to Present at Jefferies 2012 Global Healthcare Conference

Mon, May 28, 2012

[ Mon, May 28th 2012 ] - Market Wire

Immunovaccine Announces Results of 2012 Annual General Meeting

[ Mon, May 28th 2012 ] - Market Wire

Ceapro Reports First Quarter 2012 Financial Results and Provides a Corporate Update

[ Mon, May 28th 2012 ] - Market Wire

Paladin Labs and Nuvo Research Sign Canadian License Agreement for Synera and a Loan Agreement

[ Mon, May 28th 2012 ] - Market Wire

Elan to Present at Jefferies 2012 Global Healthcare Conference

Sun, May 27, 2012

[ Sun, May 27th 2012 ] - Market Wire

3SBio Inc. To Present at the DB Access Asia Conference 2012

Sat, May 26, 2012

[ Sat, May 26th 2012 ] - Market Wire

Baxters Niedrigglukose-PD-Lsungen haben sich gnst .. ausgewirkt, inklusive glykmischer Kontrolle bei S

[ Sat, May 26th 2012 ] - Market Wire

Baxters Niedrigglukose-PD-Lsungen haben sich gnst .. ausgewirkt,;;;;;;;; i

[ Sat, May 26th 2012 ] - Market Wire

Baxters Niedrigglukose-PD-Lsungen haben sich gnst .. ausgewirkt,;;;;;;;;

[ Sat, May 26th 2012 ] - Market Wire

Baxters Niedrigglukose-PD-Lsungen haben sich gnst .. ausgewirkt,;;;;;;;;

[ Sat, May 26th 2012 ] - Market Wire

Baxters Niedrigglukose-PD-Lsungen haben sich gnst .. ausgewirkt,;;;;;;;;

Fri, May 25, 2012

[ Fri, May 25th 2012 ] - Market Wire

GenVec Reports Inducement Award

[ Fri, May 25th 2012 ] - Market Wire

Endo Health Solutions Inc. to Present at the Gold .. an Sachs 33rd Annual Global Healthcare Conference

[ Fri, May 25th 2012 ] - Market Wire

Endo Health Solutions Inc. to Present at Jefferies 2012 Global Healthcare Conference

[ Fri, May 25th 2012 ] - Market Wire

Health Net Announces Appearance at Sanford C. Bernsteinas 28th Strategic Decisions Conference

[ Fri, May 25th 2012 ] - Market Wire

Study Validating miRview mets2 Published in The Oncologist

[ Fri, May 25th 2012 ] - Market Wire

Delcath Prices $20 Million Public Offering of Common Stock and Warrants

[ Fri, May 25th 2012 ] - Market Wire

InSite Vision to Webcast Annual Meeting of Stockholders on May 31, 2012

[ Fri, May 25th 2012 ] - Market Wire

Janssen and Johnson amp;; Johnson to Provi .. cast Presentation of ZYTIGA (abiraterone acetate)

[ Fri, May 25th 2012 ] - Market Wire

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

[ Fri, May 25th 2012 ] - Market Wire

Daxor Corporation Announces Filing of Form N-Q fo .. d Volumex Kit Sales for the First Quarter of 2012

[ Fri, May 25th 2012 ] - Market Wire

Boston Scientific and MELA Sciences Look to Benefit From Plan to Speed Up FDA Reviews

[ Fri, May 25th 2012 ] - Market Wire

Medtronic Resolute Stent Shows Strong Performance .. Heart Disease Patients With and Without Diabetes

[ Fri, May 25th 2012 ] - Market Wire

Depomed To Present At Jefferies 2012 Global Health Care Conference

[ Fri, May 25th 2012 ] - Market Wire

Vertex recibe opinin positiva del CHMP europeo pa .. primer medicamento para tratar las causas subyac

[ Fri, May 25th 2012 ] - Market Wire

Vertex riceve commenti positivi dal CHMP europeo .. l primo farmaco che cura la causa principale dell

[ Fri, May 25th 2012 ] - Market Wire

Vertex reoit l'aval du CHMP, section europenne, p .. emier mdicament pour le traitement de la cause so

[ Fri, May 25th 2012 ] - Market Wire

Vertex erhlt positive Stellungnahme des europisch .. tor), dem ersten Medikament zur urschlichen Behan

[ Fri, May 25th 2012 ] - Market Wire

Le soluzioni per la dialisi peritoneale a bassa c .. Baxter influiscono favorevolmente sulle misurazio

Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference

_{//health-fitness.news-articles.net/content/2012/ .. jefferies-2012-global-healthcare-conference.html}
^{Published in Health and Fitness on Thursday, May 31st 2012 at 13:32 GMT by Market Wire}

Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference -- SAN DIEGO, May 31, 2012 /PRNewswire/ --

Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference

[ ]

[ Download image ]

SAN DIEGO, May 31, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: [ HALO ]) will be presenting at the Jefferies 2012 Global Healthcare Conference in New York on Thursday, June 7, 2012 at 12:30 p.m. ET/9:30 a.m. PT.Kurt Gustafson, Chief Financial Officer, Halozyme Therapeutics, will provide a corporate overview.

(Logo: [ http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ])

The presentation will be webcast through the "Investors" section of Halozyme's corporate website at [ www.halozyme.com ], and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at [ www.halozyme.com ].

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264
[ aerickson@halozyme.com ]

SOURCE Halozyme Therapeutics, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.halozyme.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire